Literature DB >> 6325137

Interaction of insulin-like growth factors with a nonfusing mouse muscle cell line: binding, action, and receptor down-regulation.

M A de Vroede, J A Romanus, M L Standaert, R J Pollet, S P Nissley, M M Rechler.   

Abstract

Insulin and the insulin-like growth factors (IGFs) are chemically related polypeptides that interact with distinct receptors and elicit the same biological responses. We have sought a readily propagated cell line from a potential target tissue in which to probe the multiple and complex interrelationships among receptor and effector pathways for these polypeptides. We now report that the mouse muscle cell line BC3H-1 represents such a model system. BC3H-1 cells differentiate spontaneously at high density to form cells with muscle-specific properties, but do not fuse. Standaert et al. reported that differentiated BC3H-1 myocytes possess insulin receptors that mediate glucose and amino acid uptake and are down-regulated by prolonged incubation with insulin. The present report demonstrates that BC3H-1 myocytes also possess functional and regulated IGF receptors. Two subtypes of IGF receptors, types I and II, differing in structure and peptide specificity, were demonstrated by competitive binding and affinity cross-linking experiments. Low concentrations of IGFs stimulated glucose incorporation and alpha-aminoisobutyric acid uptake by BC3H-1 myocytes, suggesting that these effects were mediated primarily by IGF receptors rather than insulin receptors. Preincubation with IGFs (or high concentrations of insulin) selectively down-regulated type I IGF receptors without affecting type II IGF receptors. Since [125I]IGF-I binds to both type I and type II receptors in BC3H-1 cells, and since type I receptors have a higher affinity for IGF-I, the selective down-regulation of type I IGF receptors results in an apparent decrease in affinity for IGF-I. This difference in the regulation of type I and type II receptors in BC3H-1 myocytes is consistent with observations in other systems in which only one IGF receptor was present or examined. In their ability to be down-regulated by IGFs and insulin, type I IGF receptors are more similar to the structurally homologous insulin receptors than to the structurally dissimilar type II IGF receptors. These findings indicate that the BC3H-1 cell line provides an excellent model system in which to study the structure-function relationships of the receptor and effector pathways for insulin and the IGFs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325137     DOI: 10.1210/endo-114-5-1917

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  Specific binding of insulin-like growth factors 1 and 2 to the type 1 and type 2 receptors respectively.

Authors:  F J Ballard; M Ross; F M Upton; G L Francis
Journal:  Biochem J       Date:  1988-02-01       Impact factor: 3.857

2.  Ligand-receptor interactions involved in the stimulation of Swiss 3T3 fibroblasts by insulin-like growth factors and insulin.

Authors:  A N Corps; K D Brown
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

3.  Insulin-like effects of epidermal growth factor and insulin-like growth factor-I on [3H]2-deoxyglucose uptake, diacylglycerol generation and protein kinase C activation in BC3H-1 myocytes.

Authors:  R V Farese; G P Nair; C G Sierra; M L Standaert; R J Pollet; D R Cooper
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

4.  Regulation of insulin-like growth factor (IGF) I receptor expression during muscle cell differentiation. Potential autocrine role of IGF-II.

Authors:  S M Rosenthal; A Brunetti; E J Brown; P W Mamula; I D Goldfine
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

5.  Binding properties and biological potencies of insulin-like growth factors in L6 myoblasts.

Authors:  F J Ballard; L C Read; G L Francis; C J Bagley; J C Wallace
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

6.  Localization of sequences for the basal and insulin-like growth factor-I inducible activity of the fatty acid synthase promoter in 3T3-L1 fibroblasts.

Authors:  S Misra; K Sakamoto; N Moustaïd; H S Sul
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

7.  Stimulation and inhibition of myoblast differentiation by hormones.

Authors:  J R Florini; D Z Ewton; M J Evinger-Hodges; S L Falen; R L Lau; J F Regan; B M Vertel
Journal:  In Vitro       Date:  1984-12

8.  The receptor for insulin-like growth factor II mediates an insulin-like response.

Authors:  J Hari; S B Pierce; D O Morgan; V Sara; M C Smith; R A Roth
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

9.  Progerin modulates the IGF-1R/Akt signaling involved in aging.

Authors:  Bo Jiang; Xuan Wu; Fang Meng; Limiao Si; Sunrun Cao; Yuqing Dong; Huayi Sun; Mengzhu Lv; Hongde Xu; Ning Bai; Qiqiang Guo; Xiaoyu Song; Yang Yu; Wendong Guo; Fei Yi; Tingting Zhou; Xiaoman Li; Yanling Feng; Zhuo Wang; Dan Zhang; Yi Guan; Mengtao Ma; Jingwei Liu; Xining Li; Weidong Zhao; Baohua Liu; Toren Finkel; Liu Cao
Journal:  Sci Adv       Date:  2022-07-08       Impact factor: 14.957

10.  Epidermal growth factor controls smooth muscle alpha-isoactin expression in BC3H1 cells.

Authors:  Y C Wang; P A Rubenstein
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.